Charcot-Bouchard aneurysms revisited: clinicopathologic correlations

Shino Magaki1, Zesheng Chen2, Mohammad Haeri2,3

  • 1Section of Neuropathology, Department of Pathology and Laboratory Medicine, Ronald Reagan UCLA Medical Center and David Geffen School of Medicine, Los Angeles, CA, USA. smagaki@mednet.ucla.edu.

Insights

Charcot-Bouchard aneurysms (CBAs) are rare in elderly individuals and may not be a primary cause of intracerebral hemorrhage (ICH). These findings suggest CBAs represent severe cerebral small vessel disease, linked to hypertension and cerebral amyloid angiopathy (CAA).

Area of Science:

  • Neurology
  • Pathology
  • Vascular Biology

Background:

  • Intracerebral hemorrhage (ICH) is a major cause of death and disability globally.
  • Hypertension and cerebral amyloid angiopathy (CAA) are primary ICH causes, but hemorrhage mechanisms remain unclear.
  • Charcot-Bouchard aneurysms (CBAs) are debated as a cause of ICH, though associated with hypertensive arteriopathy and CAA.

Purpose of the Study:

  • To investigate the clinicopathologic findings and significance of Charcot-Bouchard aneurysms (CBAs) in relation to intracerebral hemorrhage (ICH).
  • To determine the prevalence and associated comorbidities of CBAs in autopsy cases.

Main Methods:

  • Retrospective analysis of over 2700 routine autopsies at a tertiary academic medical center.
  • Detailed clinicopathologic examination of identified Charcot-Bouchard aneurysms (CBAs).

Main Results:

  • Charcot-Bouchard aneurysms (CBAs) were identified in 12 cases (0.44%), predominantly in elderly individuals with multiple comorbidities.
  • Only one subject with CBAs had a large ICH; hemorrhage etiology was likely multifactorial.
  • CBAs were associated with microhemorrhages and infarcts, indicating severe cerebral small vessel disease.

Conclusions:

  • Charcot-Bouchard aneurysms (CBAs) are rare and may not be a significant direct cause of large intracerebral hemorrhage (ICH).
  • CBAs are a manifestation of severe cerebral small vessel disease, encompassing hypertensive arteriopathy and cerebral amyloid angiopathy (CAA).
  • Further research is needed to fully elucidate the role of CBAs in cerebrovascular pathology.

Related Concept Videos

Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
55
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
85
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
58
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
92
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
111
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
112